Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine

Isabel Leroux-Roels, Roger Bernhard, Pascal Gérard et al. · 2008

Read Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine by Isabel Leroux-Roels, Roger Bernhard, Pascal Gérard et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001665.txt.

Description

Isabel Leroux-Roels, Roger Bernhard, Pascal Gérard, and their co-authors tested a bird flu vaccine in a 2008 PLOS ONE research article. The vaccine was built against clade 1 H5N1, one family of the bird flu virus. It was mixed with an adjuvant, an added ingredient that boosts immune responses. A vaccine stockpiled before a pandemic must also work against other families of the virus now spreading in birds.

The team checked whether the clade 1 vaccine raised cross-reactive immunity against clade 2 viruses. The full text gives the trial design, the antibody results, and how broad the protection looked. Broad cross-clade cover is a stated requirement for a pre-pandemic vaccine plan, so these results spoke directly to how health agencies should prepare.

Catalog record

CREATORIsabel Leroux-Roels, Roger Bernhard, Pascal Gérard et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001665

Browse the full library · About the Tower of Babel